BluePath Capital Management’s Merck MRK Stock Holding History

BluePath Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.34M	Sell	10,393 -652	-6%	-$76.3K	0.73%	40
2026 Q1	$1.33M	Buy	+11,045	New	+$1.28M	0.92%	27
2024 Q4	–	Sell	-8,426	Closed	-$957K	–	108
2024 Q3	$957K	Buy	8,426 +1,728	+26%	+$205K	0.59%	37
2024 Q2	$829K	Buy	6,698 +1,297	+24%	+$167K	0.58%	38
2024 Q1	$713K	Buy	5,401 +940	+21%	+$116K	0.54%	30
2023 Q4	$530K	Buy	4,461 +940	+27%	+$97.6K	0.45%	53
2023 Q3	$363K	Buy	+3,521	New	+$380K	0.33%	62

Other funds holding MRK

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return

BluePath Capital Management's MRK Position: Q2 2026 in Review

BluePath Capital Management reduced its Merck (MRK) stake by 5.9% in Q2 2026, selling an estimated $76.3K and leaving 10,393 shares worth $1.34M. The position accounts for 0.73% of the portfolio, ranked #40.

BluePath Capital Management first reported a position in MRK in Q3 2023 and has held it in 7 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

BluePath Capital Management held 10,393 shares of Merck worth $1.34M as of Q2 2026.
BluePath Capital Management sold 652 Merck shares in Q2 2026, an estimated $76.3K.
Merck made up 0.73% of BluePath Capital Management's portfolio in Q2 2026, its #40 holding.
BluePath Capital Management first reported a position in Merck in Q3 2023 and has held it in 7 quarters since.
1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on BluePath Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.